APA

Been-Tiktak A. M., Williams I., Vrehen H. M., Richens J., Aldam D., van Loon A. M., Loveday C., Boucher C. A., Ward P., Weller I. V. & Borleffs J. C. (19970305). Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals. : Antimicrobial agents and chemotherapy.

Chicago

Been-Tiktak A M, Williams I, Vrehen H M, Richens J, Aldam D, van Loon A M, Loveday C, Boucher C A, Ward P, Weller I V and Borleffs J C. 19970305. Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals. : Antimicrobial agents and chemotherapy.

Harvard

Been-Tiktak A. M., Williams I., Vrehen H. M., Richens J., Aldam D., van Loon A. M., Loveday C., Boucher C. A., Ward P., Weller I. V. and Borleffs J. C. (19970305). Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals. : Antimicrobial agents and chemotherapy.

MLA

Been-Tiktak A M, Williams I, Vrehen H M, Richens J, Aldam D, van Loon A M, Loveday C, Boucher C A, Ward P, Weller I V and Borleffs J C. Safety, tolerance, and efficacy of atevirdine in asymptomatic human immunodeficiency virus-infected individuals. : Antimicrobial agents and chemotherapy. 19970305.